Literature DB >> 29588155

Identification of Immunodominant Th2-Cell Epitopes in Chinese Patients with Bullous Pemphigoid.

Jieyu Zhang1, Hui Fang1, Shengxian Shen1, Erle Dang1, Qiuju Li1, Pei Qiao1, Hongjiang Qiao1, Gang Wang2.   

Abstract

Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease caused by autoantibodies targeting the juxtamembranous extracellular noncollagenous 16A (NC16A) domain of human collagen XVII (also known as BP180). Because T-helper (Th) cells are essential for antibody responses to antigens, we adopted an assay to map the immunodominant Th2-cell epitopes in NC16A. We synthesized 22 overlapping peptides spanning the entire sequence of BP180-NC16A and investigated the reactivity of Th2 cells from patients with BP to these peptides using the Enzyme-Linked ImmunoSpot (ELISPOT) assay. We screened two epitope peptides, P2 (492-506 aa: VRKLKARVDELERIR) and P5 (501-515 aa: ELERIRRSILPYGDS), and confirmed that these epitopes play a dominant role in stimulating CD4+ T-cell proliferation and Th2 IL-4 cytokine production, and activating B cells to secrete autoantibodies. These immunodominant epitopes are HLA-DR-restricted and were observed in subjects with different HLA alleles. This work contributes to elucidation of the epitope-mediated immunologic pathogenesis of BP, and the identified Th2-cell epitopes are candidates for epitope-specific therapeutic strategy.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29588155     DOI: 10.1016/j.jid.2018.03.1515

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

Review 1.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

2.  Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis.

Authors:  Takashi Maehara; Naoki Kaneko; Cory A Perugino; Hamid Mattoo; Jesper Kers; Hugues Allard-Chamard; Vinay S Mahajan; Hang Liu; Samuel Jh Murphy; Musie Ghebremichael; David Fox; Aimee S Payne; Robert Lafyatis; John H Stone; Dinesh Khanna; Shiv Pillai
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

3.  Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.

Authors:  Si-Hang Wang; Ya-Gang Zuo
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

4.  An Analytically and Diagnostically Sensitive RNA Extraction and RT-qPCR Protocol for Peripheral Blood Mononuclear Cells.

Authors:  Daniel J Browne; Jamie L Brady; Ashley J Waardenberg; Claire Loiseau; Denise L Doolan
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.